Basit öğe kaydını göster

dc.contributor.authorTuzun, Yalçın
dc.contributor.authorÖzdemir, Mustafa
dc.contributor.authorYıllar, Gaye
dc.contributor.authorÜnal, Gaye
dc.contributor.authorTüzün, Binnur
dc.contributor.authorWolf, Ronni
dc.contributor.authorYillar, O
dc.date.accessioned2021-03-03T09:58:53Z
dc.date.available2021-03-03T09:58:53Z
dc.date.issued2000
dc.identifier.citationÖzdemir M., Yıllar G., Wolf R., Yillar O., Ünal G., Tüzün B., Tuzun Y., "Increased basic fibroblast growth factor levels in serum and blister fluid from patients with vitiligo", ACTA DERMATO-VENEREOLOGICA, cilt.80, sa.6, ss.438-439, 2000
dc.identifier.issn0001-5555
dc.identifier.otherav_1ffd1459-2e9a-4f91-8ea9-9a968edefc25
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/26596
dc.identifier.urihttps://doi.org/10.1080/000155500300012918
dc.description.abstractBasic fibroblast growth factor (bFGF) is a pleiotropic growth factor which has a high capacity for stimulating normal melanocyte proliferation and suppressing melanogenesis, The close and complicated relationship between bFGF, melanocyte proliferation and melanogenesis raises the theoretical possibility that bFGF may also be involved in the pathomechanism leading to vitiligo, The aim of this study was to compare the serum and suction blister fluid bFGF levels of vitiligo patients (9 females, 11 males) with those of healthy controls (3 females, 8 males). Vitiliginous skin-blister fluid bFGF levels and serum levels were significantly higher in vitiligo patients compared with healthy normal controls. Our data indicate that bFGF might be involved in the pathogenetic chain of events leading to vitiligo. Further studies are needed to define the exact role of bFGF and various other melanocytic mitogens in this disease.
dc.language.isoeng
dc.subjectDermatoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectDERMATOLOJİ
dc.titleIncreased basic fibroblast growth factor levels in serum and blister fluid from patients with vitiligo
dc.typeMakale
dc.relation.journalACTA DERMATO-VENEREOLOGICA
dc.contributor.department, ,
dc.identifier.volume80
dc.identifier.issue6
dc.identifier.startpage438
dc.identifier.endpage439
dc.contributor.firstauthorID3084


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster